![Hermann Einsele](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hermann Einsele
Corporate Officer/Principal bij Julius-Maximilians-Universität Würzburg
Oorsprong van het eerstegraads netwerk van Hermann Einsele
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Julius-Maximilians-Universität Würzburg
3
| College/University | Other Consumer Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hermann Einsele via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Corimmun GmbH
![]() Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Biotechnology | Founder Founder | |
advanceCOR GmbH
![]() advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Founder Founder | |
Helmholtz-Zentrum für Infektionsforschung GmbH
![]() Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Duitsland | 4 |
Sectoraal
Health Technology | 4 |
Operationeel
Founder | 4 |
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Sterkste connecties
Insiders | |
---|---|
Roland Jahns | 3 |
Martin Lohse | 3 |
Caroline Kisker | 2 |
- Beurs
- Insiders
- Hermann Einsele
- Bedrijfsconnecties